Aldevron, a global supplier of DNA, RNA, and protein, and Integrated DNA Technologies (IDT), a genomics solutions provider, have announced the successful production of the first personalised CRISPR gene editing drug for a paediatric patient with urea cycle disorder. Developed in partnership
TriLink BioTechnologies, a subsidiary of Maravai LifeSciences, has entered into a non-exclusive License and Supply Agreement with Aldevron, a global CDMO specialising in the production of plasmid DNA, RNA, and proteins. This partnership aims to expand access to TriLink’s CleanCap
Aldevron Contract Manufacturing & Development (CDMO) Profile Aldevron is a leading CDMO with 25+ years of experience delivering custom-manufactured and off-the-shelf solutions for cell and gene therapy development. Aldevron accelerates the path from small-scale, pre-clinical and early-phase development through to
Aldevron, a global manufacturer of DNA, RNA, and proteins, has announced a strategic partnership with Acuitas Therapeutics, a private biotechnology company that specialises in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles (LNPs). The collaboration
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
